Bio-Path Holdings, Inc.

Phase 2 biotech company developing treatments and cures for blood cancer and solid tumors.

[Bio-Path Holdings, Inc. @biopath2000]

https://t.co/fNxsimnezp

[Bio-Path Holdings, Inc. @biopath2000]

$BPTH closing in on a cross investment and partnership with https://t.co/JgBT0dU0sM using equity, looking at folding in a portion of https://t.co/GrY1y8Xigd now within $HMLA to deploy AI driven DAT 2.0 strategy vs one trick DAT 1.0 models of $MSTR $BMNR

[Bio-Path Holdings, Inc. @biopath2000]

Researching using $BIO.X to tokenize our late Phase 2 trial targeting AML and may add it to our digital treasury 2.0 plan.

$BPTH

#cancer #leukemia #biotech

[Bio-Path Holdings, Inc. @biopath2000]

@WaGon90392895 @CSchlauf @Forson @jhnwtt @Russ_N_Starr That would not be allowed it's illegal

[Bio-Path Holdings, Inc. @biopath2000]

$BPTH A data analytics provider https://t.co/XKQOrBKBpn on crypto meltdown:

https://t.co/MVHANrdw9M

[Bio-Path Holdings, Inc. @biopath2000]

$COIN has accepted our application for a business account opening us up to trade and for them to provide custodianship for our DAT 2.0 crypto plan using https://t.co/JgBT0dU0sM

$BPTH

$NSAV

[Bio-Path Holdings, Inc. @biopath2000]

$BPTH crypto DAT 2.0 platform provider integartes AI into analytics: https://t.co/7BMkBW3H2j

https://t.co/kgIoo8UUzM

$NSAV

[Bio-Path Holdings, Inc. @biopath2000]

@ericjackson @IIICapital There are other forms of collateral like $ZEC that have great features. But go get 'em Eric we are buying yur stock and certain L1 L2 for our own DAT 2.0 using AI. Keep up the good work! $BPTH

[Bio-Path Holdings, Inc. @biopath2000]

$BPTH **BREAKING NEWS**

MD Anderson has agreed to uphold our contract for Phase 2 trials of AML
(https://t.co/D7i2eLr2Pi)

Legal will provide a comfort letter to be disclosed in an 8K filing for investors and the SEC.

https://t.co/JTK1x5JRT7

#leukemia #cancer #AML #biotech

[Bio-Path Holdings, Inc. @biopath2000]

Our altfins signup code: https://t.co/cEo0OBrbBl

[Bio-Path Holdings, Inc. @biopath2000]

$BPTH becomes affiliate of https://t.co/7BMkBW3H2j; will invest using AI analytics to steer Digital Asset Treasury 2.0 (DAT 2.0) strategy targeting L1 L2 coins w/favorable chart patterns paired w/+ fundamentals vs. one-trick DAT 1.0 models that have lost billions of $.

$NSAV

[Bio-Path Holdings, Inc. @biopath2000]

Eli Lilly's top dealmaker says don't be surprised to see more M&A

https://t.co/58V4n7QfhZ

[Bio-Path Holdings, Inc. @biopath2000]

Sending proposal letter to clean up account and restart Phase 2 trial for AML. Stay tuned people it's on deck for a turnaround.

$BPTH

#leukemia #bloodcancer #cancer

[Bio-Path Holdings, Inc. @biopath2000]

@funwithfetish New management adding crypto and AI to the plan while we restart the trials and shop the biotech to a well funded player that can finish the mission.

$BPTH $NSAV

#pivot

[Bio-Path Holdings, Inc. @biopath2000]

Crypto for $BPTH digital Treasury currently targeted are $HBAR.X $ZEC.X $LINK.X $RED.X we are partnering with https://t.co/ILBqhGiEvS for AI driven crypto analysis and trading recommendations. We think one trick DAT models make no sense due to concentration risks & other factors.

[Bio-Path Holdings, Inc. @biopath2000]

@ericjackson Just put prediction markets into a PR leave Drake out or it and stock will run.

[Bio-Path Holdings, Inc. @biopath2000]

$BPTH files 8K Update:

https://t.co/9oaj3jVBWn

$NSAV

[Bio-Path Holdings, Inc. @biopath2000]

$BPTH approves DAT 2.0 using AI and L1 L2 blockchains with high on chain revenue and + tokenomics: accepts up to $10MM of funding from CEO via monetization of federal judgment against 4 defendants via custodianship of $NSAV

#leikemia #biotech #dat #ai #blockchain

[Bio-Path Holdings, Inc. @biopath2000]

Great call with MD Anderson to get back on payment plan and relaunch Phase 2 trials with additional patients to get to Phase 3 on excellent data with unique biotech approach to AML. Drawing up paperwork and action plan over the weekend.

$BPTH

#aml #biotech #cancer #leukemia

[Bio-Path Holdings, Inc. @biopath2000]

$BPTH we are speaking with MD Anderson this afternoon to refresh the contract and set terms to restart our late stage 2 trial for AML (leukemia).

#aml #leukemia #cancer #oncology

[Bio-Path Holdings, Inc. @biopath2000]

Phase 2 trial still open with MD Anderson:

https://t.co/l15ANrTBDH

$BPTH

#AML